ClinicalTrials.govpublic full text
Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis
myelodysplastic syndrome, primary myelofibrosis, mds, low+high risk mds patients, patients, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 879597
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.